Zacks Research Has Negative Estimate for TEVA Q3 Earnings
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Research analysts at Zacks Research cut their Q3 2025 earnings per share estimates for Teva Pharmaceutical Industries in a research report issued to clients and investors on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Research analysts at Zacks Research cut their Q3 2025 earnings per share estimates for Teva Pharmaceutical Industries in a research report issued to clients and investors on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of […]
-logo-1200x675.jpg?v=20230130112135&w=240&h=240&zc=2){kind=logo}
